Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Supplementary Figure S2 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Authors:
  • AOAna Oaknin
    Ana Oaknin
  • SGSharad A. Ghamande
    Sharad A. Ghamande
  • YKYuka Kasamatsu
    Yuka Kasamatsu
  • MGMarta Gil-Martin
    Marta Gil-Martin
  • JGJuan Francisco Grau-Bejar
    Juan Francisco Grau-Bejar
  • CGCarmen Garcia-Duran
    Carmen Garcia-Duran
  • MSMasashi Sato
    Masashi Sato
  • ASAbdul Siddiqui
    Abdul Siddiqui
  • SCSurendra Pal Chaudhary
    Surendra Pal Chaudhary
  • YVYulia Vugmeyster
    Yulia Vugmeyster
  • KHKosei Hasegawa
    Kosei Hasegawa

Open Access
Publisher website
Google Scholar
  • 1 March 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.25324506
Abstract
Figure S2. Change from baseline in sum of diameters of all target lesions per RECIST v1.1 for Cohort 2. CR, complete response; NE, not evaluable; PD, progressive disease; PR, partial response; SD, stable disease.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • GYNECOLOGICAL CANCERS
  • CERVICAL CANCER
  • IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.